About the initiative
The Precision Proteome Initiative is being launched by a team of dedicated scientists at Baylor College of Medicine as part of the Precision Oncology Initiative.
Not knowing how a tumor will respond to a treatment causes many patients to either undergo less effective therapies or bypass options that a tumor would respond to.
The team’s mission is to use precision oncology to improve the accuracy of the cancer diagnostic process to decrease exposure to ineffective therapies and increase access to personalized treatments that more effectively target the tumor.
Baylor College of Medicine’s cancer experts, led by renowned physician scientist Matthew Ellis, MB., BChir., Ph.D., FRCP aim to speed the delivery of these discoveries to patients with the Precision Proteome Initiative.